Tumor News and Research

RSS

Provectus to begin clinical trials of new cancer treatment, PV-10

Provectus Pharmaceuticals announced today that it has obtained final clearance to begin the first Phase 1 clinical trial of PV-10, the Company's lead cancer treatment.

21 Jul 2005

Role of IL-24 in regulating the immune system

Researchers at Introgen Therapeutics and their collaborators at The University of Texas M. D. Anderson Cancer Center have published new findings on the role of IL-24 in regulating the immune system in the current online issue of the Journal of Leukocyte Biology.

21 Jul 2005

Crucial molecular link between a hepatitis B virus (HBV) and hepatocellular carcinoma (HCC)

Researchers at The University of Texas M. D. Anderson Cancer Center have uncovered a crucial molecular link between a viral infection and development of a common and fatal form of liver cancer. In the process, they have identified a possible way to treat this disease as well as a number of other cancers.

21 Jul 2005

Benign breast disease - not necessarily an indicator of higher breast cancer risk

According to a new study, women diagnosed with a form of benign breast disease, but who do not have a strong family history of breast cancer, have no heightened risk of developing a tumor.

21 Jul 2005

Imiquimod and fluorouracil emerge as effective weapons for treating superficial basal cell carcinomas

Basal cell carcinoma, a type of skin cancer, affects millions of people worldwide. While traditional treatment has been surgery and radiation, topical treatments in combination with surgery are showing more promise for patients with basal cell carcinoma.

21 Jul 2005

New program will help fill a drug-discovery void as pharmaceutical companies have largely abandoned natural products research

The natural world has been medicine's most effective arsenal, providing life-saving antibiotics and our most potent anti-cancer drugs.

20 Jul 2005

SIRT1 gene suppresses longevity

Researchers have determined that a gene present in mouse cells limits the number of times that a cell can divide. The gene is involved in a process, called senescence, which is thought to ensure that aging cells do not pass on harmful mutations.

20 Jul 2005

New and more efficient target for antiangiogenic therapy

Scientists now have a more complete understanding of how cancer cells send signals to surrounding tissues to promote development of the blood supply needed to support tumor growth.

19 Jul 2005

Minimally invasive colorectal surgery may have a less pronounced inflammatory response

Minimally invasive colorectal surgery may have a less pronounced inflammatory response and less of a suppressing effect on the immune system than conventional surgery, resulting in a possible reduction in post-operative complications, according to a study in the July issue of Archives of Surgery.

19 Jul 2005

Studies explore genetic interactions between two well-known tumor suppressor proteins, PTEN and TSC2

Two papers in the August 1 issue of Genes & Development explore the genetic interactions between two well-known tumor suppressor proteins, PTEN and TSC2.

19 Jul 2005

Fever might be a useful weapon in the fight against cancer

A therapeutic approach for battling cancer that is based on infection with a specially designed virus similar to the one that causes the common cold has shown promise in clinical trials. Now, new research suggests that fever might be a useful weapon in the fight as well.

18 Jul 2005

New discovery could help in the fight against cancer

University of Michigan researchers have figured out one more component in cancer cells' aggressive growth - and hope that knowledge can help kill the cells.

18 Jul 2005

New finding has potentially major implications for anti-angiogenic therapy

Scientists supported by the National Institute of Dental and Craniofacial Research (NIDCR) have added a key new piece to the puzzle of how tumor cells induce new blood vessels to form and fuel their abnormal growth, a well-known process called angiogenesis.

18 Jul 2005

Compound derived from cottonseed could help improve the effectiveness of chemotherapy at treating head and neck cancer

The findings, which appear in the July issue of the journal Molecular Cancer Therapeutics, could lead to a treatment that provides an effective option to surgically removing the cancer, helping patients preserve vital organs involved in speech and swallowing.

18 Jul 2005

Asthma may be linked to a decreased risk of brain cancer

According to new research there is a suggestion that gene variants known to raise the risk of asthma, might also decrease the risk of a common type of brain cancer that progresses rapidly and is fatal.

18 Jul 2005

NIPA levels act as switch regulating cell division

Cells control mitosis (cell division) by assembling a biochemical switch to block it or by disassembling the switch to trigger it, according to investigators at St. Jude Children's Research Hospital and the Technical University of Munich.

18 Jul 2005

Asian American and Pacific Island women less likely to receive breast-conserving surgery

Asian American and Pacific Island women, particularly those born abroad, are less likely to receive breast-conserving surgery for early-stage breast cancer than non-Hispanic white women, according to a study published in the online Journal of General Internal Medicine.

17 Jul 2005

Novel treatment for ovarian cancer

The Tulane University Section of Hematology and Medical Oncology is investigating a novel treatment for ovarian cancer by using intravenous Ontak to deplete harmful cells that inhibit the body's natural immune response to fight cancer. Ovarian cancer is the fifth leading cancer killer of women in the United States.

15 Jul 2005

Having asthma, hay fever or another allergic condition may reduce the risk of developing Glioblastoma multiforme

Glioblastoma multiforme (GBM) affects three out of 100,000 people, a rate that quadruples to 13 out 100,000 among people who are 65 and older. The average five-year survival rate from the time of diagnosis for GBM is only 3.3 percent, and is lower for people 65 and older.

15 Jul 2005

New search method could aid in the discovery of biomarkers for breast cancer

Using a super-efficient method they invented to search for a type of cancer-related change in all genes of a cell, Dana-Farber Cancer Institute researchers have discovered new evidence about how the "microenvironment" of breast cancers helps drive the cancers' growth and migration.

13 Jul 2005

Tumor News and Research

Provectus to begin clinical trials of new cancer treatment, PV-10

Role of IL-24 in regulating the immune system

Crucial molecular link between a hepatitis B virus (HBV) and hepatocellular carcinoma (HCC)

Benign breast disease - not necessarily an indicator of higher breast cancer risk

Imiquimod and fluorouracil emerge as effective weapons for treating superficial basal cell carcinomas

New program will help fill a drug-discovery void as pharmaceutical companies have largely abandoned natural products research

SIRT1 gene suppresses longevity

New and more efficient target for antiangiogenic therapy

Minimally invasive colorectal surgery may have a less pronounced inflammatory response

Studies explore genetic interactions between two well-known tumor suppressor proteins, PTEN and TSC2

Fever might be a useful weapon in the fight against cancer

New discovery could help in the fight against cancer

New finding has potentially major implications for anti-angiogenic therapy

Compound derived from cottonseed could help improve the effectiveness of chemotherapy at treating head and neck cancer

Asthma may be linked to a decreased risk of brain cancer

NIPA levels act as switch regulating cell division

Asian American and Pacific Island women less likely to receive breast-conserving surgery

Novel treatment for ovarian cancer

Having asthma, hay fever or another allergic condition may reduce the risk of developing Glioblastoma multiforme

New search method could aid in the discovery of biomarkers for breast cancer

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News